FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281569596> ?p ?o ?g. }

• W4281569596 endingPage "675" @default.
• W4281569596 startingPage "666" @default.
• W4281569596 abstract "We retrospectively evaluated outcomes after radiation therapy for patients with oligoprogression on immune checkpoint inhibitors (ICI).We identified patients irradiated to ≤5 progressive lesions while receiving ICI between 2010 and 2020. We excluded patients whose systemic therapy was switched after radiation but before progression. We evaluated predictors of local control (LC), progression-free survival (PFS) and overall survival (OS).We screened 1423 patients and identified 120 who were eligible; the most common histologies were lung cancer (n = 59) and melanoma (n = 36). The median number of oligoprogressive lesions was 1. For the median LC of irradiated oligoprogressive lesions, PFS and OS were not reached at 6.41 (4.67-7.66) and 29.80 (22.54-43.33) months, respectively. Tumor histology, radiated site, or radiation modality were not associated with LC, PFS, or OS. Local response to radiation (P < .0001) and radiation of newly developed lesions (P = .02) were associated with LC. Predictors of PFS on univariate and multivariate analyses were best response to radiation (P = .006) and high programmed death ligand 1 tumor proportion score (P = .02). On multivariate analyses, OS was associated with cumulative oligoprogressive lesion volumes (P = .02) and duration of ICI before oligoprogression (P = .03).Promising outcomes were observed among patients irradiated for oligoprogression on ICI, especially those with a favorable local response, high tumor programmed death ligand 1 expression, and those receiving ICI for longer periods before oligoprogression. These data can help identify patients well suited for radiation therapy versus those who should switch systemic treatment." @default.
• W4281569596 created "2022-05-27" @default.
• W4281569596 creator A5007463236 @default.
• W4281569596 creator A5021987743 @default.
• W4281569596 creator A5022694627 @default.
• W4281569596 creator A5024024612 @default.
• W4281569596 creator A5041066193 @default.
• W4281569596 creator A5051390263 @default.
• W4281569596 creator A5061916285 @default.
• W4281569596 creator A5063910724 @default.
• W4281569596 creator A5064724289 @default.
• W4281569596 creator A5074572669 @default.
• W4281569596 creator A5083203430 @default.
• W4281569596 creator A5086249998 @default.
• W4281569596 creator A5091434259 @default.
• W4281569596 date "2022-11-01" @default.
• W4281569596 modified "2023-10-14" @default.
• W4281569596 title "Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade" @default.
• W4281569596 cites W2030227571 @default.
• W4281569596 cites W2753065806 @default.
• W4281569596 cites W2761351587 @default.
• W4281569596 cites W2788208686 @default.
• W4281569596 cites W2791856118 @default.
• W4281569596 cites W2793750722 @default.
• W4281569596 cites W2939770857 @default.
• W4281569596 cites W2944301866 @default.
• W4281569596 cites W2950824232 @default.
• W4281569596 cites W2956407134 @default.
• W4281569596 cites W2958415056 @default.
• W4281569596 cites W2963626381 @default.
• W4281569596 cites W2996784175 @default.
• W4281569596 cites W2997721110 @default.
• W4281569596 cites W3010374810 @default.
• W4281569596 cites W3015860015 @default.
• W4281569596 cites W3019546741 @default.
• W4281569596 cites W3080889076 @default.
• W4281569596 cites W3089068548 @default.
• W4281569596 cites W4206362366 @default.
• W4281569596 cites W4206748384 @default.
• W4281569596 doi "https://doi.org/10.1016/j.ijrobp.2022.05.008" @default.
• W4281569596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35643252" @default.
• W4281569596 hasPublicationYear "2022" @default.
• W4281569596 type Work @default.
• W4281569596 citedByCount "4" @default.
• W4281569596 countsByYear W42815695962022 @default.
• W4281569596 countsByYear W42815695962023 @default.
• W4281569596 crossrefType "journal-article" @default.
• W4281569596 hasAuthorship W4281569596A5007463236 @default.
• W4281569596 hasAuthorship W4281569596A5021987743 @default.
• W4281569596 hasAuthorship W4281569596A5022694627 @default.
• W4281569596 hasAuthorship W4281569596A5024024612 @default.
• W4281569596 hasAuthorship W4281569596A5041066193 @default.
• W4281569596 hasAuthorship W4281569596A5051390263 @default.
• W4281569596 hasAuthorship W4281569596A5061916285 @default.
• W4281569596 hasAuthorship W4281569596A5063910724 @default.
• W4281569596 hasAuthorship W4281569596A5064724289 @default.
• W4281569596 hasAuthorship W4281569596A5074572669 @default.
• W4281569596 hasAuthorship W4281569596A5083203430 @default.
• W4281569596 hasAuthorship W4281569596A5086249998 @default.
• W4281569596 hasAuthorship W4281569596A5091434259 @default.
• W4281569596 hasConcept C121608353 @default.
• W4281569596 hasConcept C126322002 @default.
• W4281569596 hasConcept C143998085 @default.
• W4281569596 hasConcept C144301174 @default.
• W4281569596 hasConcept C167135981 @default.
• W4281569596 hasConcept C170493617 @default.
• W4281569596 hasConcept C2777658100 @default.
• W4281569596 hasConcept C2777701055 @default.
• W4281569596 hasConcept C2778468042 @default.
• W4281569596 hasConcept C2780851360 @default.
• W4281569596 hasConcept C38180746 @default.
• W4281569596 hasConcept C502942594 @default.
• W4281569596 hasConcept C509974204 @default.
• W4281569596 hasConcept C71924100 @default.
• W4281569596 hasConceptScore W4281569596C121608353 @default.
• W4281569596 hasConceptScore W4281569596C126322002 @default.
• W4281569596 hasConceptScore W4281569596C143998085 @default.
• W4281569596 hasConceptScore W4281569596C144301174 @default.
• W4281569596 hasConceptScore W4281569596C167135981 @default.
• W4281569596 hasConceptScore W4281569596C170493617 @default.
• W4281569596 hasConceptScore W4281569596C2777658100 @default.
• W4281569596 hasConceptScore W4281569596C2777701055 @default.
• W4281569596 hasConceptScore W4281569596C2778468042 @default.
• W4281569596 hasConceptScore W4281569596C2780851360 @default.
• W4281569596 hasConceptScore W4281569596C38180746 @default.
• W4281569596 hasConceptScore W4281569596C502942594 @default.
• W4281569596 hasConceptScore W4281569596C509974204 @default.
• W4281569596 hasConceptScore W4281569596C71924100 @default.
• W4281569596 hasIssue "4" @default.
• W4281569596 hasLocation W42815695961 @default.
• W4281569596 hasLocation W42815695962 @default.
• W4281569596 hasOpenAccess W4281569596 @default.
• W4281569596 hasPrimaryLocation W42815695961 @default.
• W4281569596 hasRelatedWork W2013727445 @default.
• W4281569596 hasRelatedWork W2089462794 @default.
• W4281569596 hasRelatedWork W2515434604 @default.
• W4281569596 hasRelatedWork W2619461121 @default.
• W4281569596 hasRelatedWork W274490372 @default.

• next